Nauman Shah, J&J global head for business development
J&J’s dealmaker: Plenty of ‘firepower,’ but mostly focused on tuck-in M&A
SAN DIEGO — The head of dealmaking at Johnson & Johnson said that biotech valuations have come back down to more reasonable levels that make it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
